OCS · Oculis Holding AG
$12.94
+0.12 (+0.94%)
At close · Aug 14
Market Cap
$718.53M
Shares
55.53M
Oculis Holding AG Earnings Call Transcripts
Every quarterly earnings call for Oculis Holding AG (OCS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY26 · Q3
2026-11-05
Q3-2026 Earnings Release
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-06
Q2-2026 Earnings Release
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-10
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-29
DIAMOND Phase 3 Topline Results Conference Call
Cautious tone
OCS-01 Phase 3 DIAMOND results
Regulatory strategy for OCS-01
Licaminumab (PREDICT-1) in dry eye
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-16
Needham Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-03-03
Q4/Full Year Earnings Release
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–6 of 6 earnings calls
Key facts
CIK
1953530
CUSIP
H5870P102
13F (30d)
61 filings
61 filers
Visit website
Investor relations